Catalyst Wire Dossier Catalyst Wire Dossier

WEVEE

trivalent virus-like particle encephalitis vaccine · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WEVEE, covering 2021-03-19 to 2021-03-19. Get the full timeline:

Most recent: Clinical Trial Update: VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults [Phase 1]

See pricing